[1]
|
邹晓辉, 曹彬. 呼吸道感染病原学诊断年度进展2021[J]. 中华结核和呼吸杂志, 2022, 45: 78-82. |
[2]
|
World Health Organization. Global Health Estimates: Life expectancy and leading causes of death and disability[EB/OL]. (2021-05-03)[2023-07-30]. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates. |
[3]
|
瞿介明, 刘海霞. 病原体分子诊断技术在下呼吸道感染诊断中的应用及其价值[J]. 中华结核和呼吸杂志, 2019, 42: 486-489. |
[4]
|
Hanson KE, Azar MM, Banerjee R, et al. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diag-nostic Recommendations From the IDSA's Diagnostics Committee[J]. Clin Infect Dis, 2020, 71: 2744-2751. doi: 10.1093/cid/ciaa508 |
[5]
|
Tenover FC. The role for rapid molecular diagnostic tests for infectious diseases in precision medicine[J]. Expert Rev Precis Med Drug Dev, 2018, 3: 69-77. doi: 10.1080/23808993.2018.1425611 |
[6]
|
北京协和医院罕见病多学科协作组, 中国罕见病联盟. 多准则决策分析应用于罕见病药品临床综合评价的专家共识(2022)[J]. 协和医学杂志, 2022, 13: 126-145. doi: 10.12290/xhyxzz.2022-0013 |
[7]
|
刘高山, 李红, 牛培华, 等. 多重核酸检测试剂盒RespiFinder® 2SMART在检测12种呼吸道感染病毒中的临床应用性能评价[J]. 国际病毒学杂志, 2020, 27: 61-66. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSY202305015.htm |
[8]
|
中国合格评定国家认可委员会. 临床化学定量检验程序性能验证指南: CNAS-GL037-2019[S]. 北京: 中国合格评定国家认可委员会, 2019. |
[9]
|
Deng H, Gao Z. Bioanalytical applications of isothermal nucleic acid amplification techniques[J]. Anal Chim Acta, 2015, 853: 30-45. doi: 10.1016/j.aca.2014.09.037 |
[10]
|
姜苏, 李一荣. 等温扩增技术的原理及应用[J]. 中华检验医学杂志, 2020, 43: 591-596. https://www.cnki.com.cn/Article/CJFDTOTAL-DYJZ201708023.htm |
[11]
|
中国合格评定国家认可委员会. 分子诊断检验程序性能验证指南: CNAS-GL039[S]. 北京: 中国合格评定国家认可委员会, 2019. |
[12]
|
Kuypers J, Jerome KR. Applications of Digital PCR for Clinical Microbiology[J]. J Clin Microbiol, 2017, 55: 1621-1628. doi: 10.1128/JCM.00211-17 |
[13]
|
ISO. 20395: 2019 Biotechnology-Requirements for evaluating the performance of quantification methods for nucleic acid target sequences--qPCR and dPCR[S/OL]. (2019-08)[2023-07-20]. https://www.doc88.com/p-5803961087245.html. |
[14]
|
上海市医学会分子诊断专科分会, 上海市医学会检验医学专科分会, 上海市微生物学会临床微生物学专业委员会, 等. 病原体核酸即时检测质量管理要求专家共识[J]. 中华检验医学杂志, 2021, 44: 1021-1028. |
[15]
|
Chiu CY, Miller SA. Clinical metagenomics[J]. Nat Rev Genet, 2019, 20: 341-355. doi: 10.1038/s41576-019-0113-7 |
[16]
|
中华医学会呼吸病学分会. 下呼吸道感染宏基因组二代测序报告临床解读路径专家共识[J]. 中华结核和呼吸杂志, 2023, 46: 322-335. https://xuewen.cnki.net/CCND-YSBZ20230223B021.html |
[17]
|
《中华传染病杂志》编辑委员会. 中国宏基因组学第二代测序技术检测感染病原体的临床应用专家共识[J]. 中华传染病杂志, 2020, 38: 681-689. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYX202107002.htm |
[18]
|
宏基因组分析和诊断技术在急危重症感染应用的专家共识组. 宏基因组分析和诊断技术在急危重症感染应用的专家共识[J]. 中华急诊医学杂志, 2019, 28: 151-155. |
[19]
|
Bharucha T, Oeser C, Balloux F, et al. STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies[J]. Lancet Infect Dis, 2020, 20: e251-e260. doi: 10.1016/S1473-3099(20)30199-7 |
[20]
|
中华医学会检验医学分会. 宏基因组测序病原微生物检测生物信息学分析规范化管理专家共识[J]. 中华检验医学杂志, 2021, 44: 799-807. |
[21]
|
中华医学会细菌感染与耐药防治分会. 呼吸系统感染中宏基因组测序技术临床应用与结果解读专家共识[J]. 中华临床感染病杂志, 2022, 15: 90-102. |
[22]
|
张栋, 张京家, 杜娟, 等. 病原宏基因组高通量测序性能确认方案[J]. 中华检验医学杂志, 2022, 45: 899-905. |
[23]
|
Miller S, Naccache SN, Samayoa E, et al. Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid[J]. Genome Res, 2019, 29: 831-842. |
[24]
|
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa[J]. Clin Infect Dis, 2019, 68: e1-e47. |
[25]
|
Lee BY, McGlone SM, Bailey RR, et al. To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling[J]. PLoS One, 2010, 5: e11284. |
[26]
|
Brendish NJ, Malachira AK, Beard KR, et al. Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: apost hoc analysis from a randomised controlled trial[J]. Eur Respir J, 2018, 52: 1800555. |
[27]
|
Shengchen D, Gu X, Fan G, et al. Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial[J]. Clin Microbiol Infect, 2019, 25: 1415-1421. |
[28]
|
Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis[J]. Pediatrics, 2014, 134: e1474-e1502. |
[29]
|
钟文, 吴凡, 吴建, 等. 病毒性肺炎治疗新进展[J]. 中华结核和呼吸杂志, 2022, 45: 121-126. |
[30]
|
施毅. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志, 2018, 41: 255-280. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYI202109010.htm |
[31]
|
Kalil AC, Metersky ML, Klompas M, et al. Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society[J]. Clin Infect Dis, 2016, 63: 575-582. |
[32]
|
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44: 170-205. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202129002.htm |
[33]
|
Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359: 2355-2365. |
[34]
|
Ye F, He LX, Cai BQ, et al. Spectrum and antimicrobial resistance of common pathogenic bacteria isolated from patients with acute exacerbation of chronic obstructive pulmonary disease in mainland of China[J]. Chin Med J (Engl), 2013, 126: 2207-2214. |
[35]
|
Ma X, Cui J, Wang J, et al. Multicentre investigation of pathogenic bacteria and antibiotic resistance genes in Chinese patients with acute exacerbation of chronic obstruc-tive pulmonary disease[J]. J Int Med Res, 2015, 43: 699-710. |
[36]
|
江雁琼, 伍慧妍, 文艳琼. 慢阻肺急性加重期感染病原菌分布与机体免疫功能检测及其临床意义[J]. 中国病原生物学杂志, 2019, 14: 213-216. https://www.cnki.com.cn/Article/CJFDTOTAL-ZISC201902019.htm |
[37]
|
国家卫生健康委办公厅国家中医药管理局办公室. 关于印发流行性感冒诊疗方案(2020年版)的通知[EB/OL ]. (2022-10-04)[2023-07-20]. http://www.nhc.gov.cn/yzygj/s7653p/202011/a943c67d55c74e589d23c81d65b5e221.shtml. |
[38]
|
Lyon SM, Rossman MD. Pulmonary Tuberculosis[J]. Microbiol Spectr, 2017. doi: 10.1128/microbiolspec.TNMI7-0032-2016. |
[39]
|
Centers for Disease Control and Prevention. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis[J]. MMWR Morb Mortal Wkly Rep, 2009, 58: 7-10. |
[40]
|
Yan L, Xiao H, Zhang Q. Systematic review: Comparison of Xpert MTB/RIF, LAMP and SAT methods for the diagnosis of pulmonary tuberculosis[J]. Tuberculosis (Edinb), 2016, 96: 75-86. |
[41]
|
Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tubercul-osis and rifampicin resistance: a prospective multicentre diagnostic accuracy study[J]. Lancet Infect Dis, 2018, 18: 76-84. |
[42]
|
Scott C, Kirking HL, Jeffries C, et al. Tuberculosis trends--United States, 2014[J]. MMWR Morb Mortal Wkly Rep, 2015, 64: 265-269. |
[43]
|
Gopi A, Madhavan SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in 2006[J]. Chest, 2007, 131: 880-889. |
[44]
|
Zhou X, Wu H, Ruan Q, et al. Clinical Evaluation of Diagnosis Efficacy of Active Mycobacterium tuberculosis Complex Infection via Metagenomic Next-Generation Sequencing of Direct Clinical Samples[J]. Front Cell Infect Microbiol, 2019, 9: 351. |
[45]
|
Timsit JF, Sonneville R, Kalil AC, et al. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients[J]. Intensive Care Med, 2019, 45: 573-591. |
[46]
|
张弦, 顾宇峰, 赵华, 等. 宏基因组学二代测序在免疫功能受损不明原因肺部感染患者病原鉴别中的意义[J]. 交通医学, 2020, 34: 242-245. https://www.cnki.com.cn/Article/CJFDTOTAL-JTYX202003007.htm |
[47]
|
Ramirez JA, Musher DM, Evans SE, et al. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies[J]. Chest, 2020, 158: 1896-1911. |
[48]
|
王瑜琼, 黄琳娜, 詹庆元. 肺孢子菌肺炎诊断方法的研究进展[J]. 中华结核和呼吸杂志, 2020, 43: 878-880. https://www.cnki.com.cn/Article/CJFDTOTAL-YJYX202206015.htm |
[49]
|
Chen J, Zhao Y, Shang Y, et al. The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe pneumonia[J]. J Med Microbiol, 2021. doi: 10.1099/jmm.0.001259. |
[50]
|
石炳毅, 肖漓, 孙丽莹. 器官移植受者巨细胞病毒感染临床诊疗规范(2019版)[J]. 器官移植, 2019, 10: 142-148. https://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201902005.htm |
[51]
|
Manuel O, Estabrook M. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33: e13511. |
[52]
|
Miller J. Michael. 临床微生物标本送检指南[M]. 马小军, 周炯, 杨启文, 等译. 北京: 布克(北京)文化传播有限公司, 2013. |
[53]
|
Gilbert DN, Chambers HF, Saag MS, et al. The Sanford Guide to antimicrobial therapy 2020[M]. 50th edtion. 北京: 中国协和医科大学出版社, 2021. |
[54]
|
国家卫健委全国细菌耐药监测网质量管理中心. 感染性疾病病原学检测标本采集及转运指导原则[M]. 北京: 中国协和医科大学出版社, 2020. |